|
|
DSpace ISS >
Browsing by Author Palmisano, Lucia
Showing results 1 to 20 of 63
| Issue Date | Title | Author(s) | | 2011 | A brief history of antiretroviral therapy of HIV infection: success and challenges | Palmisano, Lucia; Vella, Stefano |
| 1998 | Aggiornamento sulla terapia dell'infezione da HIV | Palmisano, Lucia; Vella, Stefano |
| 2004 | Andamento clinico, immunologico e virologico di donne HIV positive in terapia con HAART per 48 mesi | Sarmati, Loredana; Palmisano, Lucia; Angeletti, Claudio; Chiesi, Antonio; Nicastri, Emanuele; Geraci, Andrea; Vella, Stefano; Andreoni, Massimo |
| 2005 | Andamento dei livelli di HIV-DNA in corso di HAART | Andreoni, Massimo; Sarmati, Loredana; Palmisano, Lucia; Angeletti, Claudio; Chiesi, Antonio; Nicastri, Emanuele; Geraci, Andrea; Vella, Stefano |
| 1999 | Antiretroviral therapy: keynote trials of 1998 | Palmisano, Lucia; Vella, Stefano |
| 2000 | Antiretroviral therapy: state of the HAART | Vella, Stefano; Palmisano, Lucia |
| 2005 | Association between cellular human immunodeficiency virus DNA level and immunological parameters in patients with undetectable plasma viremia level during highly active antiretroviral therapy | Sarmati, Loredana; Parisi, Saverio Giuseppe; Nicastri, Emanuele; D'Ettorre, Gabriella; Palmisano, Lucia; Andreotti, Mauro; Andreoni, Carolina; Giuliano, Marina; Gatti, Francesca; Boldrin, Caterina; Palù, Giorgio; Vullo, Vincenzo; Vella, Stefano; Andreoni, Massimo |
| 2004 | Baseline predictors and virological outcome in subjects developing mutations during intermittent HAART | Palmisano, Lucia; Giuliano, Marina; Pirillo, Maria Franca; Galluzzo, Clementina Maria; Andreotti, Mauro; Bucciardini, Raffaella; Nicastri, Emanuele; Fragola, Vincenzo; Andreoni, Massimo; Vella, Stefano |
| 2003 | Beyond lipodystrophy: will toxicity issues ever outweigh the benefits of HAART? | Vella, Stefano; Palmisano, Lucia |
| 2005 | Clinical outcome after 4 years follow-up in HIV-seropositive subjects with incomplete virologic or immunologic response to HAART | Nicastri, Emanuele; Chiesi, Antonio; Angeletti, Claudio; Sarmati, Loredana; Palmisano, Lucia; Geraci, Andrea; Andreoni, Massimo; Vella, Stefano |
| 2005 | Clinical outcome after 4 years follow-up in HIV-seropositive subjects with incomplete virologic or immunologic response to HAART | Italian antiretroviral treatment group (IATG); Nicastri, Emanuele; Chiesi, Antonio; Angeletti, Claudio; Sarmati, Loredana; Palmisano, Lucia; Geraci, Andrea; Andreoni, Massimo; Vella, Stefano |
| 2004 | Clinical, virological, and immunological outcomes of female patients treated with HAART for 48 months | Italian antiretroviral treatment group (IATG); Sarmati, Loredana; Palmisano, Lucia; Angeletti, Claudio; Chiesi, Antonio; Nicastri, Emanuele; Geraci, Andrea; Vella, Stefano; Andreoni, Massimo |
| 2009 | Design, synthesis and microbiological studies on new inhibitors of HIV virus integrase | Palmisano, Lucia; Cianfriglia, Maurizio; Di Santo, Roberto; Palamara, Anna Teresa; Pommier, Yves |
| 2007 | Determinants of virologic and immunologic outcome in chronically HIV-infected subjects undergoing repeated treatment interruptions: the Istituto Superiore di Sanità-Pulsed Antiretroviral Therapy (ISS-PART) study | Palmisano, Lucia; Giuliano, Marina; Bucciardini, Raffaella; Fragola, Vincenzo; Andreotti, Mauro; Galluzzo, Clementina Maria; Pirillo, Maria Franca; Weimer, Liliana Elena; Arcieri, Romano; Germinario, Elena Angela Pia; Amici, Roberta; Mancini, Maria Grazia; d'Arminio Monforte, Antonella; Castelli, Francesco; Caramello, Pietro; Vella, Stefano; Palio, Elisabetta |
| 2006 | Development of human immunodeficiency virus vector-based, single-cycle assay for evaluation of anti-integrase compounds | Bona, Roberta; Andreotti, Mauro; Buffa, Viviana; Leone, Pasqualina; Galluzzo, Clementina Maria; Amici, Roberta; Palmisano, Lucia; Mancini, Maria Grazia; Michelini, Zuleika; Di Santo, Roberto; Costi, Roberta; Roux, Alessandra; Pommier, Yves; Marchand, Christophe; Vella, Stefano; Cara, Andrea |
| 2002 | Discordant response to antiretroviral therapy: HIV isolation, genotypic mutations, T-cell proliferation and cytokine production | D'Ettorre, Gabriella; Forcina, Gabriele; Andreotti, Mauro; Sarmati, Loredana; Palmisano, Lucia; Galluzzo, Clementina Maria; Nicastri, Emanuele; Mastroianni, Claudio M; Vullo, Vincenzo; Vella, Stefano; Andreoni, Massimo |
| 2009 | Disegno, sintesi, attività e funzione di nuovi inibitori dell'integrasi dell'HIV | Palmisano, Lucia; Cianfriglia, Maurizio; Di Santo, Roberto; Palamara, Anna Teresa; Pommier, Yves |
| 2003 | Drug-associated resistance mutations in plasma and peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected patients from whom highly active antiretroviral therapy is failing | Sarmati, Loredana; Nicastri, Emanuele; Uccella, Ilaria; D'Ettorre, Gabriella; Parisi, Saverio Giuseppe; Palmisano, Lucia; Galluzzo, Clementina Maria; Concia, Ercole; Vullo, Vincenzo; Vella, Stefano; Andreoni, Massimo |
| 2004 | Emergence of resistance mutations during intermittent HAART. Rate, predicting factors, and effect on virologic response | Palmisano, Lucia; Giuliano, Marina; Bucciardini, Raffaella; Galluzzo, Clementina Maria; Andreotti, Mauro; Fragola, Vincenzo; Arcieri, Romano; Amici, Roberta; Weimer, Liliana Elena; Germinario, Elena Angela Pia; Pirillo, Maria Franca; Vella, Stefano; Palio, Elisabetta |
| 2011 | European recommendations for the clinical use of HIV drug resistance testing: 2011 update | European HIV Drug Resistance Guidelines Panel; Vandamme, Anne-Mieke; Camacho, Ricardo J; Ceccherini Silberstein, Francesca; De Luca, Andrea; Palmisano, Lucia; Paraskevis, Dimitrios; Paredes, Roger; Poljak, Mario; Schmit, Jean-Claude; Soriano, Vincent; Walter, Hauke; Sönnerborg, Anders |
Showing results 1 to 20 of 63
|
